Calcium Hopantenate Hemihydrate powder manufacturer CAS No.: 17097-76-6 98.0% purity min. for supplement ingredients
Product Parameters
|
Product name |
Calcium Hopantenate Hemihydrate |
|
Other name |
CALCIUMHOPANTENATEHEMIHYDRATE; CALCIUMD-(+)-4-(2,4-DIHYDROXY-3,3-DIMETHYLBUTYLAMIDO)BUTYRATEHEMIHYDRATE; pantogam;vivant; Butanoicacid,4-[(2,4-dihydroxy-3,3-dimethyl-1-oxobutyl)amino]-,calciumsalt(2:1),(R)-;Butanoicacid,4-[[(2R)-2,4-dihydroxy-3,3-dimethyl-1-oxobutyl]amino]-,calciumsalt(2:1); Butyricacid,4-(2,4-dihydroxy-3,3-dimethylbutyramido)-,calciumsalt(2:1),D-(+)-(8CI);D-(+)-Homopantothenicacidcalciumsalt |
|
CAS No. |
17097-76-6 |
|
Molecular formula |
C20H38CaN2O11 |
|
Molecular weight |
522.6 |
|
Purity |
98.0% |
|
Appearance |
powder |
|
Application |
Dietary Supplement Raw Material |
Product introduction
Calcium hopantenate hemihydrate, also known as calcium 2-aminoethanesulfonate N-hydroxyethane-1,2-diamine-2,2-diolate hemihydrate, is a pharmaceutical compound used in the treatment of cognitive disorders and memory impairment. It is derived from hopantenic acid, which is a derivative of pantethine (a component of coenzyme A).
Calcium hopantenate hemihydrate is believed to enhance brain function by increasing cerebral metabolism and blood flow, as well as improving the synthesis and release of acetylcholine, a neurotransmitter involved in memory and learning processes. It has been used as a therapeutic agent for various conditions, including age-related memory decline, vascular dementia, and Alzheimer's disease.
This compound is typically available in the form of oral tablets or capsules. The recommended dosage and treatment duration may vary depending on the specific condition being treated and the individual's response to the medication. It is important to follow the instructions provided by the prescribing healthcare professional or the medication's packaging.
As with any medication, calcium hopantenate hemihydrate may have potential side effects. Common side effects may include gastrointestinal disturbances such as nausea, vomiting, and diarrhea. In rare cases, allergic reactions or hypersensitivity reactions may occur. If you experience any unusual or severe side effects while taking this medication, it is important to seek medical attention immediately.
It is worth noting that medication information can change over time, and new research or formulations may become available. Therefore, it is always best to consult with a healthcare professional or refer to the most recent prescribing information and guidelines for the most accurate and up-to-date information on calcium hopantenate hemihydrate or any other medication.
Feature
(1) High purity: Calcium Hopantenate Hemihydrate can be obtained with high purity through natural extraction and precise manufacturing processes. High purity means better bioavailability and fewer adverse reactions.
(2) Safety: Calcium Hopantenate Hemihydrate is a medication compound that has been proven to be safe for human use. Within the recommended dosage range, it has no toxicity or side effects.
(3) Stability: Calcium Hopantenate Hemihydrate exhibits good stability and can maintain its activity and effectiveness under different environmental and storage conditions.
(4) Easy absorption: Calcium Hopantenate Hemihydrate can be quickly absorbed by the human body, entering the bloodstream through the intestinal tract and distributing to various tissues and organs.
Applications
Currently, Calcium Hopantenate Hemihydrate has gained significant application in the treatment of cognitive disorders and memory impairment. It is widely used in clinical practice for its potential to enhance cerebral metabolism, improve blood flow, and modulate neurotransmitter systems involved in memory and learning processes. Calcium Hopantenate Hemihydrate has shown promising results in ameliorating age-related memory decline, vascular dementia, and Alzheimer's disease.
The application prospects of Calcium Hopantenate Hemihydrate are also promising. Ongoing research and clinical trials are exploring its potential therapeutic benefits in other neurodegenerative disorders, such as Parkinson's disease and Huntington's disease. Additionally, the compound's safety profile and favorable pharmacokinetic properties make it an attractive candidate for combination therapies and synergistic approaches with other cognitive-enhancing agents.
Furthermore, the development of novel formulations and delivery systems may further improve the efficacy and patient compliance of Calcium Hopantenate Hemihydrate. These advancements may include extended-release formulations, transdermal patches, or targeted drug delivery methods to enhance its bioavailability and provide sustained therapeutic effects.
In summary, Calcium Hopantenate Hemihydrate currently holds a significant position in the treatment of cognitive disorders, and its potential applications in other neurodegenerative conditions indicate promising prospects for future therapeutic advancements. Further research and development efforts will likely contribute to maximizing its clinical utility and expanding its role in neurological healthcare.
